This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Spring 2023 Quarterly Report provides summaries of most key patentlaw-related decisions from January 1, 2023 to March 31, 2023. We are excited to share Sheppard Mullin’s inaugural quarterly report on key Federal Circuit decisions. Click here to read more.
Image from here IP Court watchers will be pleased to know that the Delhi High Court’s IP Division has published the 2023-24 edition of its Annual Report ! Praharsh had written about the first report published in April 2023. A total of 1977 cases across patents, copyrights and trademarks, were received from the IPAB in 2022.
In Plant-e v Bioo the UPC provided its first decision addressing the doctrine of equivalents in patent infringement proceedings ( UPC_CFI_239/2023 ). Legal background: Equivalence around Europe The Unified Patent Court Agreement (UPCA) contains no specific provisions on the doctrine of equivalence.
Thank you to readers who voted for the IPKat book of the year awards 2023! Here are the nominees and winners: Best PatentLaw Book The nominations, in no particular order, were: • Der patentrechtliche Schutz von Daten und seine Grenzen; Landscheidt, by Fabian Landscheidt. The Unitary Patent Package and Unified Patent Court. .
16, 2023) , the case addresses the Board’s anticipation and obviousness determinations in two IPRs (IPR2020-00002 and IPR2020-00004), where the Board held the claims in the challenged patents unpatentable as anticipated by, or obvious in view of, the asserted prior art. Patent Nos. In Incept v. 6,624,245 to Wallace et al.
In our annual review of developments in Canadian patentlaw, we considered over 60 patent decisions reported last year. This article highlights statutory changes and a selection of interesting points addressed in the reported decisions. By: Smart & Biggar
Rajya Sabha MP Haris Beeran wrote to the Minister of Health and Family Welfare on December 20, 2024, urging the Central Government to invoke Section 100 (1) of the Patents Act with respect to local production of the rare disease Spinal Muscular Atrophy (SMA) treating drug Risdiplam. 72 lakhs for children (12 bottles) and Rs 1.86
The Court held that Amgen’s patent claims were invalid due to a lack of enablement, as they failed to provide adequate guidance for making and using the claimed antibodies. — (2023) ( 21-757_k5g1 ). The case in question is Amgen Inc. Sanofi , 22-157, — U.S.
by Dennis Crouch The following is my patentlaw exam from this past semester. This year’s exam is very loosely based upon an interesting patent that I found associated with the Tow Whee product created by Eric Landis. After talking again with Jane, EL decided to patent the device. Question 3. What do you think?
by Dennis Crouch The Supreme Court is set to consider several significant patentlaw petitions addressing a range of issues from the application of obviousness standards, challenges to PTAB procedures, interpretation of joinder time limits IPR, to the proper scope patent eligibility doctrine. Mangrove Partners Master Fund, No.
Recently, the new Rules for the Implementation of PatentLaw (hereinafter referred to as "the Rules") has been approved and promulgated by the State Council, and will come into force on January 20, 2024. There are many amendments in the new Rules, and we have summarized the need-to-know points for your reference.
Recently, the new Rules for the Implementation of PatentLaw (hereinafter referred to as "the Rules") has been approved and promulgated by the State Council, and will come into force on January 20, 2024. There are many amendments in the new Rules, and we have summarized the need-to-know points for your reference.
On December 11, 2023, the State Council of the People’s Republic of China announced its decision to amend the Implementing Regulations of the PatentLaw of the People’s Republic of China (the “2023 Regulations”), marking the first update in over 13 years since the last amendment in 2010.
Supreme Court granted Amgen’s petition to review the “enablement requirement” of Section 112 of the Patent Act. The Court’s decision will likely come in the late second quarter of 2023 and could require significant strategic adjustments by patent owners and prosecutors. See generally Amgen Inc., Sanofi, No. 21-757 (U.S.
PATENTS The arena of patents has evolved with time, and in contemporary times, the scope of subject matter that is patentable has also evolved, which in turn has modified the requirements of patents. As contemporary technology has developed, the patent system has faced fresh difficulties.
In Thaler v Comptroller-General of Patents, Designs and Trade Marks [2023] UKSC 49, the UK Supreme Court ruled that AI cannot be an ‘inventor’ for the purposes of UK patentlaw.
by Dennis Crouch Impact of Sonos on Patent Prosecution : The recent Sonos v. Google decision threatens to grind to a halt, or at least significantly restrict, a once-common patent prosecution strategy – keeping continuation applications pending for years to obtain new claims that cover marketplace developments. 6, 2023).
by Dennis Crouch The USPTO is officially establishing a separate design patent practitioner bar with its final rule published on November 16, 2023 and effective January 2, 2024. Currently, a single patent bar governs registration for anyone seeking to practice before the USPTO in utility, plant, and design patent matters.
We are pleased to see that Banaras Hindu University is organizing the 10th Mahamana Malaviya National Moot Court Competition, with the problem for this year’s competition surrounding patentlaw and incremental innovations. The competition is from 24th March- 26th March 2023. This edition of the competition is based on patents.
Registration at UKIPO The case in question, originating in 2019, presents a groundbreaking legal dilemma: Can an artificial intelligence (AI) system be acknowledged as an inventor for the purposes of patent ownership? At the heart of this case lies a critical examination of the UK Patent Act 1977, specifically Section 13(2).
Fish & Richardson is pleased to announce that the firm has been named a “Law Firm of the Year” for Litigation – Intellectual Property and Litigation – Patent in U.S. News & World Report – Best Lawyers “Best Law Firms” 2023 edition. Litigation – Patent . PatentLaw . Technology Law .
OpenAI has the reputation for protecting its innovations through the use of trade secrets as opposed to patents. This is perhaps not surprising, given that patent applications are not published until 18 months after they are filed, and that OpenAI's major innovation of ChatGPT was first released about 2 years ago. Who are OpenAI?
PatKat reviewing the year It is time once more for the IPKat patent year in review! Pour yourself a glass of mulled wine, curl up with your favourite feline and catch-up on your EPO case law. At the very least, LLMs have substantially lessened the burden of sourcing cat-themed patent blog illustrations.
On January 26, 2023, the US Patent and Trademark Office (USPTO) conducted a public roundtable, during which various attorneys and industry experts discussed their thoughts on the intersection of patentlaw with non-fungible tokens (NFTs). By: ArentFox Schiff
I just gave a short (45 min) talk about the past year in patentlaw. See the slides here: Patent Year in Review. Patents as Commodity : Many folks are treating it as such. Vidal cert petition likely in January 2023. Patent Venue : Lots still happening in W.D.Tex. by Dennis Crouch. Sanofi and Juno v.
We are pleased to share Sheppard Mullin’s inaugural “Year in Review” report that collects and reports on most key patentlaw-related Federal Circuit decisions for 2023. This is a follow up to the quarterly report we introduced in Spring 2023, which was very well received.
By Jason Rantanen I’m getting ready to teach my Fall 2023PatentLaw class, and that means updating the granted utility patents graph that I do every few years. In contrast, at the end of July 2022 there were 186,500 patents listed on the Authority file.) I included patents that are marked as Withdrawn.
In the Hatch-Waxman arena of patent litigation, the crisscross of patentlaws and FDA regulations is always in play. Avadel CNS Pharmaceuticals, LLC, 2023 WL 2198640 (Fed. 24, 2023), we see another iteration of this with respect to listing a method-of-use patent in the Orange Book. By: Locke Lord LLP
21-757) on Monday, March 27, 2023. The highly contentious question before the high court focuses what an applicant must show to meet the enablement requirement of patentlaw. The Supreme Court is set to hear oral arguments in Amgen, Inc. Sanofi (No. By: Bradley Arant Boult Cummings LLP
769 on December 21, 2023 to enact the Implementing Regulations of the PatentLaw (Amended in 2023) (hereinafter referred to as “the Implementing Regulations (Amended in 2023)”) as of January 20, 2024. China’s state council issued State Council Degree No. By: Linda Liu & Partners
In a noteworthy year for patentlaw, the U.S. Court of Appeals for the Federal Circuit issued several decisions that will shape the patent landscape and the Federal Rules of Evidence governing expert testimony were amended. Supreme Court and the U.S. By: Smith Anderson
Minerva and Hologic, competitors selling devices used for ablating uterine endometrial tissue, are notable for their dispute last year that gave the Supreme Court an opportunity to reassess an established patentlaw doctrine, assignor estoppel (reminiscent of the Court's review of the Federal Circuit's standard for obviousness in KSR Int'l v.
Following the same mission, the Indian Patent Office has taken a drive to dispose off the patent applications in a quicker way, provided all the procedures are properly attended by the applicant. In the way, an application was filed on 13/07/2022 for obtaining the patent protection for an Indian Applicant.
Constitution authorizes Congress to legislatively create a patent system. And, Congress has so since the beginning, with George Washington signing the the First Patent Act into law in 1790. As Congress continued to legislatively develop the statute, courts also added common law nuance, including the law of patent eligibility.
Kartikeya is a second-year law student of the LL.B. Having freelanced as a patent research analyst, he developed an interest in patent prosecution and in exploring the Patents Act through various interpretative approaches. He is currently engaged in WIPO-Harvard Law School Course in PatentLaw and Global Public Health.
The Indian Patent Office (IPO) is set to hear objections against Gilead Sciences’ patent claims for Lenacapavir, an HIV drug. This situation highlights the ongoing struggle between patent protections and access to essential medicines. The looming threat is the pending patent applications by Gilead in India.
16, 2023), the case addresses the Board’s anticipation and obviousness determinations in two IPRs (IPR2020-00002 and IPR2020-00004), where the Board held the claims in the challenged patents unpatentable as anticipated by, or obvious in view of, the asserted prior art. In Incept v. Palette Life Sciences 21-2063, 21-2065 (Fed.
But why does annual Belgian patent review come at the end of Summer every year? Brussels Court of Appeal, 30 January 2023, Biogen v. Mylan In this typical preliminary injunction (PI) case, the Brussels Court of Appeal seems to have refined its case-law. Is the wind shifting. ? The dispute arose between Biogen and Mylan.
On December 21, 2023, more than three years after the amendments to the PatentLaw in 2020 (2020 PatentLaw), the Implementation Regulations of the PatentLaw (Rules) and the Guidelines for Patent Examination (Guidelines) were issued and came into force on January 20, 2024.
This change represents a considerable shift in the intellectual property law landscape within the country, aiming to promote an environment of genuine innovation and integrity. Improper Transfer: Transferring or acquiring patent application rights for improper purposes.
Supreme Court, who died in December 2023, this article examines women's representation in the legal industry and in patentlaw. While an increasing number of women earn law degrees, women continue to be underrepresented as practicing attorneys and in leadership positions.
by Dennis Crouch One of the more shocking patent decisions of 2023 was Judge Alsup’s holding in Sonos, Inc. C 20-06754 WHA, 2023 WL 6542320 (N.D. The scathing opinion left two Sonos multi-zone smart-speaker patents unenforceable due to prosecution laches and a rejection of the $32 million jury verdict.
We are pleased to bring to you this sponsored post by IP Press on the extension of the registration deadlines for their Comprehensive Course on Patents, in collaboration with S. The IP Press presents the third cohort of the Comprehensive Course on Patents. Majumdar & Co.who are experts in the field of Patents.
We organize all of the trending information in your field so you don't have to. Join 9,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content